(Q55417340)

8 July 2018

title

Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. (English)

1 reference

8 July 2018

11

Cem Gabay

1 reference

8 July 2018

13

Edward M Behrens

1 reference

8 July 2018

author name string

Scott W Canna

1

1 reference

8 July 2018

Charlotte Girard

2

1 reference

8 July 2018

Louise Malle

3

1 reference

8 July 2018

Adriana de Jesus

4

1 reference

8 July 2018

Neil Romberg

5

1 reference

8 July 2018

Judith Kelsen

6

1 reference

8 July 2018

Lea F Surrey

7

1 reference

8 July 2018

Pierre Russo

8

1 reference

8 July 2018

Andrew Sleight

9

1 reference

8 July 2018

Eduardo Schiffrin

10

1 reference

8 July 2018

Raphaela Goldbach-Mansky

12

1 reference

8 July 2018

language of work or name

English

0 references

publication date

19 November 2016

1 reference

8 July 2018

The Journal of Allergy and Clinical Immunology

published in

1 reference

8 July 2018

volume

139

1 reference

8 July 2018

page(s)

1698-1701

1 reference

8 July 2018

issue

5

1 reference

8 July 2018

Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

Elevated serum levels of free interleukin-18 in adult-onset Still's disease.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5846100

10.1016/J.JACI.2016.10.022

12 August 2018

Identifiers

DOI

1 reference

8 July 2018

PMCID

5846100

1 reference

8 July 2018

PubMed ID

27876626

1 reference

8 July 2018